smartwater Announces Zendaya as Newest Global Brand Ambassador
smartwater is taking hydration to new heights this summer and today announces its newest global brand ambassador, Zendaya. A champion of artistry and originality, acclaimed actor and performer Zendaya is pioneering new ways to live a more purposeful life. As smartwater’s global ambassador, Zendaya will appear in a series of new creative from the brand that celebrates those who are defining ‘smart’ on their own terms and will support community water programs that will directly impact thousands of women.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220621005427/en/
Courtesy of The Coca-Cola Company
“We could not be more thrilled to have Zendaya join smartwater as the newest face of our brand,” said Matrona Filippou, Global Category President, Hydration, Sports, Tea & Coffee, The Coca-Cola Company. “A global icon and cultural force, Zendaya isn’t afraid to be true to herself, and that’s what makes her the perfect addition to the smartwater family.”
Created in partnership with VMLY&R and WPP/OpenX, the campaign creative will begin rolling out in the U.S. from June 21 across television, audio, social and streaming channels, with global markets to follow. The campaign celebrates those who keep it smart, whatever the choice, and aren’t afraid to free themselves from the restraints of convention.
“I’m very excited to begin this new relationship with smartwater,” said Zendaya, smartwater Global Brand Ambassador. “We all know how important it is to stay hydrated and smartwater is my go-to source no matter what I am doing throughout the day.”
As the face of the brand’s newest campaign, Zendaya will work with smartwater to support community water quality and access improvements in various cities around the world, starting with Zendaya’s hometown of Oakland, California, by partnering with the Global Water Challenge (GWC) – a coalition of leading organizations collaborating to achieve universal access to clean drinking water. In the U.S. alone, 2.2 million people have no water at home and 44 million Americans are served by water systems that don't function optimally.
Together, smartwater, GWC and Zendaya are launching the smart solutions: global water challenge, which will invite local organizations to apply for grant funding to GWC’s women for water action platform that uplifts women and their communities through the power of clean water access. These efforts build on more than a decade of investments in clean water access around the world from The Coca-Cola Company which have reached more than 18.5 million people since 2010. GWC’s work has proven that with access to clean water, people, especially women and girls, are healthier, safer, educated and employed.
“Our organization doesn’t operate without the support of our purpose-driven partners, and we are grateful to have smartwater and Zendaya on board to help ensure communities in need have more access to clean water,” says Monica Ellis, CEO of Global Water Challenge. “With the smart solutions: global water challenge, we’ll specifically work to address community water access, improving and protecting water quality, and economic empowerment opportunities through water.”
For more information about smartwater, visit smartwater.com. For more information about the Global Water Challenge and the smart solutions: global water challenge, visit www.globalwaterchallenge.org.
About The Coca-Cola Company
The Coca-Cola Company (NYSE: KO) is a total beverage company with products sold in more than 200 countries and territories. Our company’s purpose is to refresh the world and make a difference. We sell multiple billion-dollar brands across several beverage categories worldwide. Our portfolio of sparkling soft drink brands includes Coca-Cola, Sprite and Fanta. Our hydration, sports, coffee and tea brands include Dasani, smartwater, vitaminwater, Topo Chico, BODYARMOR, Powerade, Costa, Georgia, Gold Peak and Ayataka. Our nutrition, juice, dairy and plant-based beverage brands include Minute Maid, Simply, innocent, Del Valle, fairlife and AdeS. We’re constantly transforming our portfolio, from reducing sugar in our drinks to bringing innovative new products to market. We seek to positively impact people’s lives, communities and the planet through water replenishment, packaging recycling, sustainable sourcing practices and carbon emissions reductions across our value chain. Together with our bottling partners, we employ more than 700,000 people, helping bring economic opportunity to local communities worldwide. Learn more at www.coca-colacompany.com and follow us on Twitter, Instagram, Facebook and LinkedIn.
About The Global Water Challenge
Global Water Challenge (GWC) is a coalition of leading organizations deploying expertise and networks to achieve universal access to safe and affordable drinking water, sanitation, and hygiene (WASH) in communities around the world. Since 2006, GWC has positively impacted more than 2 million people across Africa, the Americas and Asia with clean water access and its campaigns, tools, data and best practices reach millions more. In collaboration with multi-sector partners, GWC engages for action – catalyzing financial resources and driving innovative programming for sustainable, local solutions. GWC established the women for water platform to mobilize collective action for clean water access for every woman and her community. Currently scaling impact in 27 countries, women for water measurably contributes to economic empowerment outcomes while raising awareness for this important issue. For more information, please visit globalwaterchallenge.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220621005427/en/
Contact information
Media: press@coca-cola.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release
Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
